Found 601 matching trials
Study of CAR-T Cell Therapy in the Treatment of Relapsed/Refractory Hematological Malignancies
PHASE1The primary purpose of this study is to determine the safety and efficacy o...
Location
The Affiliated People's Hospital of Ningbo University
A Combination Study of CAR-T Therapy in r/r B-NHL
PHASE2In registry studies of CAR-T products that have been marketed globally, pat...
Location
Ruijin Hospital, Shanghai Jiao Tong University School of Medicine
Study of IFN-α Combined With CAR-T Cell Therapy in Relapsed and Refractory Acute Lymphoblastic Leukemia(R/R-ALL)
PHASE2The purpose of this study is to evaluate the safety and efficacy of IFN-α c...
Location
The First Affiliated Hospital of Soochow University
Clinical Study of Chimeric Antigen Receptor T Lymphocytes (CAR-T) in the Treatment of Relapsed/Refractory Non-Hodgkin Lymphoma
PHASE1This is a phase I clinical study to evaluate the safety and efficacy of CAR...
Location
Shandong Second Provincial General Hospital
CD4 CAR+ ZFN-modified T Cells in HIV Therapy
PHASE1This research study is being carried out to study a new way to possibly tre...
Status
Active Not Recruiting
Location
University of Pennsylvania
Anti-CD19 CAR T-Cell Therapy in Refractory Systemic Autoimmune Diseases
PHASE1The CATARSIS study explores the use of anti-CD19 CAR T-cell therapy as a no...
Location
Fondazione Policlinico Universitario A. Gemelli IRCCS
A Study of CCT301-59 CAR T Therapy in Adult Subjects With Recurrent or Refractory Solid Tumors
PHASE1This clinical study is to investigate the safety and tolerability of CAR mo...
Location
Shanghai Zhongshan Hospital
Safety and Efficacy of GYA01 (CART84) in Relapsed/Refractory (R/R) Acute Myeloid Leukemia (AML) and Acute Lymphoblastic T Leukemia Patients (T-ALL).
PHASE1This Phase I/IIa clinical study is testing an experimental treatment called...
Location
Hospital Clínic de Barcelona
A Study of a Fully Human BCMA-targeting CAR (CT103A) Combined With Selinexor in Patients With Relapsed/Refractory Extramedullary Multiple Myeloma
PHASE1This study is a single-center, open Phase I study, to observe the effective...
Location
Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology
Safety and Efficacy of CT125A Cells for Treatment of Relapsed/Refractory CD5+ Hematopoietic Malignancies
EARLY_PHASE1Current treatments for relapsed/refractory hematopoietic malignancies such ...
Location
Multiple Locations